Literature DB >> 21208161

The contribution of mannose binding lectin to reperfusion injury after ischemic stroke.

Helena Morrison1, Jennifer Frye, Grace Davis-Gorman, Janet Funk, Paul McDonagh, Gregory Stahl, Leslie Ritter.   

Abstract

After complement system (CS) activation, the sequential production of complement products increases cell injury and death through opsonophagocytosis, cytolysis, adaptive, and inflammatory cell responses. These responses potentiate cerebral ischemia-reperfusion (IR) injury after ischemic stroke and reperfusion. Activation of the CS via mannose binding lectin (MBL)-initiated lectin pathway is known to increase tissue damage in response to IR in muscle, myocardium and intestine tissue. In contrast, the contribution of this pathway to cerebral IR injury, a neutrophil-mediated event, is less clear. Therefore, we investigated the potential protective role of MBL deficiency in neutrophil-mediated cerebral injury after IR. Using an intraluminal filament method, neutrophil activation and cerebral injury were compared between MBL-deficient and wild type C57Bl/6 mice subjected to 60 minutes of MCA ischemia and reperfusion. Systemic neutrophil activation was not decreased in MBL-deficient animals after IR. In MBL-deficient animals, cerebral injury was significantly decreased only in the striatum (p < 0.05). Despite MBL deficiency, C3 depositions were evident in the injured hemisphere during reperfusion. These results indicate that while MBL deficiency results in a modest protection of a sub-cortical brain region during IR, redundant complement pathway activation may overwhelm further beneficial effects of MBL deficiency during reperfusion.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208161      PMCID: PMC3512100          DOI: 10.2174/156720211794520260

Source DB:  PubMed          Journal:  Curr Neurovasc Res        ISSN: 1567-2026            Impact factor:   1.990


  52 in total

1.  Extra-hepatic transcription of the human mannose-binding lectin gene (mbl2) and the MBL-associated serine protease 1-3 genes.

Authors:  Jeanette Seyfarth; Peter Garred; Hans O Madsen
Journal:  Mol Immunol       Date:  2005-08-19       Impact factor: 4.407

Review 2.  Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.

Authors:  J O Sunyer; H Boshra; J Li
Journal:  Vet Immunol Immunopathol       Date:  2005-10-18       Impact factor: 2.046

3.  C1Q synthesis by tissue mononuclear phagocytes from normal and from damaged rat liver: up-regulation by dexamethasone, down-regulation by interferon gamma, and lipopolysaccharide.

Authors:  T Armbrust; B Nordmann; M Kreissig; G Ramadori
Journal:  Hepatology       Date:  1997-07       Impact factor: 17.425

4.  Role of complement component C5 in cerebral ischemia/reperfusion injury.

Authors:  Cristina Costa; Limin Zhao; Yamin Shen; Xiao Su; Liming Hao; Sean P Colgan; Gregory L Stahl; Tong Zhou; Yi Wang
Journal:  Brain Res       Date:  2006-06-15       Impact factor: 3.252

5.  Mannan-binding lectin recognizes structures on ischaemic reperfused mouse kidneys and is implicated in tissue injury.

Authors:  M Møller-Kristensen; W Wang; M Ruseva; S Thiel; S Nielsen; K Takahashi; L Shi; A Ezekowitz; J C Jensenius; M Gadjeva
Journal:  Scand J Immunol       Date:  2005-05       Impact factor: 3.487

6.  Mannose-binding lectin is a regulator of inflammation that accompanies myocardial ischemia and reperfusion injury.

Authors:  Mary C Walsh; Todd Bourcier; Kazue Takahashi; Lei Shi; Marc N Busche; Russell P Rother; Scott D Solomon; R Alan B Ezekowitz; Gregory L Stahl
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

7.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

Authors:  J Huang; L J Kim; R Mealey; H C Marsh; Y Zhang; A J Tenner; E S Connolly; D J Pinsky
Journal:  Science       Date:  1999-07-23       Impact factor: 47.728

8.  The administration of cobra venom factor reduces post-ischemic cerebral injury in adult and neonatal rats.

Authors:  Estuardo Figueroa; Laura E Gordon; Pamela W Feldhoff; Herbert A Lassiter
Journal:  Neurosci Lett       Date:  2005-02-02       Impact factor: 3.046

9.  Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q.

Authors:  Melanie L Hart; Kathleen A Ceonzo; Lisa A Shaffer; Kazue Takahashi; Russell P Rother; Wende R Reenstra; Jon A Buras; Gregory L Stahl
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

10.  C5a, interleukin-8 and tumour necrosis factor-alpha-induced changes in granulocyte and monocyte expression of complement receptors in whole blood and on isolated leukocytes.

Authors:  M Furebring; L Håkansson; P Venge; J Sjölin
Journal:  Scand J Immunol       Date:  2006-03       Impact factor: 3.487

View more
  15 in total

1.  The alternative complement pathway propagates inflammation and injury in murine ischemic stroke.

Authors:  Andrew Elvington; Carl Atkinson; Hong Zhu; Jin Yu; Kazue Takahashi; Gregory L Stahl; Mark S Kindy; Stephen Tomlinson
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

2.  The Neuroprotective Effect of Genetic Mannose-binding Lectin Deficiency is not Sustained in the Sub-acute Phase of Stroke.

Authors:  Andrew F Ducruet; Sergey A Sosunov; Brad E Zacharia; Justin Gorski; Mason L Yeh; Peter Derosa; Gregory Cohen; Paul R Gigante; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2011-08-23       Impact factor: 6.829

3.  Pathogenic natural antibodies propagate cerebral injury following ischemic stroke in mice.

Authors:  Andrew Elvington; Carl Atkinson; Liudmila Kulik; Hong Zhu; Jin Yu; Mark S Kindy; V Michael Holers; Stephen Tomlinson
Journal:  J Immunol       Date:  2011-12-23       Impact factor: 5.422

4.  TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation.

Authors:  Michael R Pope; Sherry D Fleming
Journal:  J Immunol       Date:  2014-12-24       Impact factor: 5.422

Review 5.  Injury site-specific targeting of complement inhibitors for treating stroke.

Authors:  Ali Alawieh; Stephen Tomlinson
Journal:  Immunol Rev       Date:  2016-11       Impact factor: 12.988

6.  Inhibition of Complement Drives Increase in Early Growth Response Proteins and Neuroprotection Mediated by Salidroside After Cerebral Ischemia.

Authors:  Wenfang Lai; XiuLi Xie; Xiaoqin Zhang; Yingzheng Wang; Kedan Chu; John Brown; Lidian Chen; Guizhu Hong
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

Review 7.  Complement activation in the injured central nervous system: another dual-edged sword?

Authors:  Faith H Brennan; Aileen J Anderson; Stephen M Taylor; Trent M Woodruff; Marc J Ruitenberg
Journal:  J Neuroinflammation       Date:  2012-06-21       Impact factor: 8.322

Review 8.  Complement in the Homeostatic and Ischemic Brain.

Authors:  Ali Alawieh; Andrew Elvington; Stephen Tomlinson
Journal:  Front Immunol       Date:  2015-08-12       Impact factor: 7.561

9.  Mannan-Binding Lectin Is Involved in the Protection against Renal Ischemia/Reperfusion Injury by Dietary Restriction.

Authors:  Shushimita Shushimita; Pieter van der Pol; Ron W F de Bruin; Jan N M Ijzermans; Cees van Kooten; Frank J M F Dor
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

Review 10.  Mannan-binding lectin in cardiovascular disease.

Authors:  Izabela Pągowska-Klimek; Maciej Cedzyński
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.